A detailed history of 111 Capital transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, 111 Capital holds 3,310 shares of LNTH stock, worth $250,765. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,310
Holding current value
$250,765
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$78.23 - $110.01 $258,941 - $364,133
3,310 New
3,310 $323 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.21B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track 111 Capital Portfolio

Follow 111 Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 111 Capital, based on Form 13F filings with the SEC.

News

Stay updated on 111 Capital with notifications on news.